Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Tesla
TSLA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
TNYA Tenaya Therapeutics
- 1.400
- +0.010+0.72%
Close Jan 17 16:00 ET
- 1.380
- -0.020-1.43%
Post 20:01 ET
110.91MMarket Cap-0.97P/E (TTM)
1.425High1.360Low1.45MVolume1.400Open1.390Pre Close2.02MTurnover2.63%Turnover RatioLossP/E (Static)79.22MShares7.01052wk High0.99P/B77.23MFloat Cap0.98752wk Low--Dividend TTM55.17MShs Float32.000Historical High--Div YieldTTM4.70%Amplitude0.987Historical Low1.393Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Tenaya Therapeutics Stock Forum
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones
Monday, 13th January at 9:16 am
Continued Focus on Driving Advancement of TN-201 and TN-401 Gene Therapies for Cardiomyopathies
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
Additional Cohort 1 Data to be Reported in 1H25 Building on Promising Initial Data
Initial Data from RIDG...
No comment yet